Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Expert Review of Clinical Immunology|June 9, 2021
The IL-4, IL-13 and IL-31 pathways in atopic dermatitisCelina Dubin, Ester Del Duca, Emma Guttman-Yassky
Expert Review of Proteomics|May 25, 2021
Proteomic signatures of inflammatory skin diseases: a focus on atopic dermatitisDaniela Mikhaylov, Ester Del Duca, Emma Guttman-Yassky
Therapeutics and Clinical Risk Management|January 7, 2021
Drugs for the Treatment of Chronic Hand Eczema: Successes and Key ChallengesCelina Dubin, Ester Del Duca, Emma Guttman-Yassky
Cellular & Molecular Immunology|March 17, 2023
The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatmentPaola Facheris, Jane Jeffery, Ester Del Duca, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 26, 2023
Diversity of atopic dermatitis and selection of immune targetsCamille Rothenberg-Lausell, Jonathan Bar, Ester Del Duca, et al.
The Journal of Dermatological Treatment|December 5, 2018
Rapid, persistent, and simultaneous remission of urticaria and severe atopic dermatitis after treatment with omalizumabEster Del Duca, Maria Esposito, Stefania Lechiancole, et al.
Expert Opinion on Biological Therapy|June 18, 2024
Monoclonal antibodies for moderate-to-severe atopic dermatitis: a look at phase III and beyondEden David, Kelly Hawkins, Neda Shokrian, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|March 23, 2018
Reducing the oral isotretinoin skin side effects: efficacy of 8% omega-ceramides, hydrophilic sugars, 5% niacinamide cream compound in acne patientsMaria V Cannizzaro, Annunziata Dattola, Virginia Garofalo, et al.
International Journal of Molecular Sciences|November 13, 2020
Cytokine Pathways and Investigational Target Therapies in Hidradenitis SuppurativaEster Del Duca, Paola Morelli, Luigi Bennardo, et al.
International Journal of Immunopathology and Pharmacology|February 15, 2018
Cost-efficacy analysis of 3% diclofenac sodium, ingenol mebutate, and 3.75% imiquimod in the treatment of actinic keratosisSteven Nisticò, Ester Del Duca, Valeria Torchia, et al.
Pageof 12